Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Dova treatment of chemotherapy-induced thrombocytopenia granted orphan status » 12:03
12/20/19
12/20
12:03
12/20/19
12:03
DOVA

Dova Pharmaceuticals

$28.06 /

+ (+0.00%)

Dova…

Dova Pharmaceuticals' treatment of chemotherapy-induced thrombocytopenia was granted FDA orphan designation, according to a post to the agency's website. Reference Link

ShowHide Related Items >><<
DOVA Dova Pharmaceuticals
$28.06 /

+ (+0.00%)

10/09/19 Oppenheimer
Dova Pharmaceuticals moved to Not Rated at Oppenheimer
10/04/19 Wedbush
Dova Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
10/03/19
Fly Intel: Top five analyst upgrades
10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
Options
Three new option listings and two option delistings on November 13th » 08:30
11/13/19
11/13
08:30
11/13/19
08:30
CNST

Constellation Pharmaceuticals

$32.64 /

-1.74 (-5.06%)

, INSW

International Seaways

$25.57 /

+0.54 (+2.16%)

, DF

Dean Foods

/

+

, DOVA

Dova Pharmaceuticals

$28.06 /

+ (+0.00%)

New option listings for…

New option listings for November 13th include Constellation Pharmaceuticals Inc (CNST), Dean Foods Company New (DFODQ), and International Seaways (INSW). Option delistings effective November 13th include Dean Foods Company New (DF) and Dova Pharmaceuticals Inc (DOVA).

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$32.64 /

-1.74 (-5.06%)

11/07/19 Jefferies
Constellation Pharmaceuticals price target raised to $40 from $17 at Jefferies
11/07/19 RBC Capital
Constellation Pharmaceuticals price target raised to $42 from $20 at RBC Capital
11/07/19 H.C. Wainwright
Constellation price target raised to $50 from $18 at H.C. Wainwright
11/06/19 Oppenheimer
Constellation Pharmaceuticals price target raised to $40 from $18 at Oppenheimer
INSW International Seaways
$25.57 /

+0.54 (+2.16%)

11/05/19 BTIG
BTIG raises price targets on tanker shipping names
10/11/19 BTIG
International Seaways initiated with a Buy rating at BTIG
04/24/19 Stifel
U.S. sanctions on Iran could benefit crude tankers, says Stifel
12/06/18 Jefferies
International Seaways 'very attractive' play on tanker recovery, says Jefferies
DF Dean Foods
/

+

11/12/19 BMO Capital
BMO discontinues coverage of Dean Foods, sees 'little hope' for equity
03/08/19 JPMorgan
Dean Foods upgraded to Neutral from Underweight at JPMorgan
02/27/19 Stifel
Stifel sees Dean Foods falling after Q4 report despite strategic review
02/27/19 JPMorgan
Avoid the 'temptation' to buy Dean Foods on takeout thesis, says JPMorgan
DOVA Dova Pharmaceuticals
$28.06 /

+ (+0.00%)

10/09/19 Oppenheimer
Dova Pharmaceuticals moved to Not Rated at Oppenheimer
10/04/19 Wedbush
Dova Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
10/03/19
Fly Intel: Top five analyst upgrades
10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
Options
Largest borrow rate increases among liquid names » 08:45
10/28/19
10/28
08:45
10/28/19
08:45
HOME

At Home Group

$10.35 /

+0.37 (+3.71%)

, AM

Antero Midstream

$7.42 /

+0.1 (+1.37%)

, OSTK

Overstock.com

$11.29 /

+0.59 (+5.51%)

, HIIQ

Health Insurance Innovations

$27.05 /

+0.25 (+0.93%)

, JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$64.25 /

+2.29 (+3.70%)

, DOVA

Dova Pharmaceuticals

$28.30 /

-0.05 (-0.18%)

, NEPT

Neptune Wellness

$3.51 /

+0.01 (+0.29%)

, UUUU

Energy Fuels

$1.94 /

+0.01 (+0.52%)

, MT

ArcelorMittal

$15.47 /

+0.465 (+3.10%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: At Home Group (HOME) 1.47% +0.98, Antero Midstream (AM) 35.80% +0.95, Overstock com (OSTK) 16.06% +0.60, Health Insurance Innovations (HIIQ) 34.10% +0.52, Direxion Junior Gold (JNUG) 1.26% +0.35, Dova Pharmaceuticals (DOVA) 8.27% +0.33, Neptune Technologies (NEPT) 19.48% +0.27, Energy Fuels (UUUU) 6.62% +0.24, ArcelorMittal (MT) 0.83% +0.15, and Proshares Ultrapro 3x Crude Oil ETF (OILU) 2.52% +0.10.

ShowHide Related Items >><<
HOME At Home Group
$10.35 /

+0.37 (+3.71%)

08/20/19 BofA
At Home Group price target lowered to $5 from $8 at BofA/Merrill
06/10/19
Fly Intel: Top five analyst downgrades
06/10/19 Morgan Stanley
Morgan Stanley cuts At Home Group to Equal Weight with headwinds seen persisting
06/10/19 Morgan Stanley
At Home Group downgraded to Equal Weight from Overweight at Morgan Stanley
AM Antero Midstream
$7.42 /

+0.1 (+1.37%)

10/03/19 JPMorgan
Antero Midstream reinstated with a Neutral rating at JPMorgan
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Raymond James
Antero Midstream downgraded to Market Perform from Outperform at Raymond James
08/01/19 MUFG
Antero Midstream downgraded to Neutral from Overweight at MUFG
OSTK Overstock.com
$11.29 /

+0.59 (+5.51%)

09/26/19 BofA
Aaron's initiated with a Buy at BofA/Merrill
09/19/19 DA Davidson
Overstock.com stake sale by former CEO Byrne a positive, says DA Davidson
07/16/19 Maxim
Overstock.com resumed with a Buy at Maxim
07/10/19 DA Davidson
Overstock tech stack would be valuable to strategic buyers, says DA Davidson
HIIQ Health Insurance Innovations
$27.05 /

+0.25 (+0.93%)

09/25/19 B. Riley FBR
Health Insurance should be bought on yesterday's selloff, says B. Riley FBR
09/20/19
Health Insurance Innovations management to meet with B. Riley FBR
08/16/19 Piper Sandler
Teladoc short report selloff brings buying opportunity, says Piper Jaffray
08/13/19 Cantor Fitzgerald
Health Insurance cash flow not major concern, says Cantor Fitzgerald
JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$64.25 /

+2.29 (+3.70%)

DOVA Dova Pharmaceuticals
$28.30 /

-0.05 (-0.18%)

10/09/19 Oppenheimer
Dova Pharmaceuticals moved to Not Rated at Oppenheimer
10/04/19 Wedbush
Dova Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
10/03/19
Fly Intel: Top five analyst upgrades
10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
NEPT Neptune Wellness
$3.51 /

+0.01 (+0.29%)

04/09/19
Neptune Wellness initiated with a Buy at GMP Securities
UUUU Energy Fuels
$1.94 /

+0.01 (+0.52%)

05/13/19 Noble Capital
Energy Fuels downgraded to Market Perform from Outperform at Noble Capital
MT ArcelorMittal
$15.47 /

+0.465 (+3.10%)

10/07/19 Deutsche Bank
ArcelorMittal price target lowered to $18 from $25 at Deutsche Bank
09/03/19 Credit Suisse
ArcelorMittal initiated with an Outperform at Credit Suisse
06/26/19 Jefferies
Nucor flat rolled price increase likely to help sentiment, says Jefferies
06/12/19 Goldman Sachs
ArcelorMittal upgraded to Buy from Neutral at Goldman Sachs
Recommendations
Dova Pharmaceuticals moved to Not Rated at Oppenheimer » 07:31
10/09/19
10/09
07:31
10/09/19
07:31
DOVA

Dova Pharmaceuticals

$28.16 /

-0.03 (-0.11%)

Oppenheimer analyst…

Oppenheimer analyst Justin Kim moved to Not Rated from Outperform on Dova Pharmaceuticals following Swedish Orphan Biovitrum's offer to acquire the company. The analyst believes there is limited merger risk exists for the deal, noting that Swedish Orphan Biovitrum holds the right commercial footprint, without significant overlap to trigger FTC complications.

ShowHide Related Items >><<
DOVA Dova Pharmaceuticals
$28.16 /

-0.03 (-0.11%)

10/04/19 Wedbush
Dova Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
10/03/19
Fly Intel: Top five analyst upgrades
10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/03/19 JPMorgan
Dova Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan
Downgrade
Dova Pharmaceuticals downgraded to Neutral from Outperform at Wedbush » 07:29
10/04/19
10/04
07:29
10/04/19
07:29
DOVA

Dova Pharmaceuticals

$28.24 /

+0.04 (+0.14%)

Wedbush analyst Laura…

Wedbush analyst Laura Chico downgraded Dova Pharmaceuticals to Neutral from Outperform but raised her price target to $29 from $24 following the announcement of an acquisition bid by Swedish Orphan Biovitrum. Chico tells investors in a research note that she sees limited room for upside with the stock now trading above $28.

ShowHide Related Items >><<
DOVA Dova Pharmaceuticals
$28.24 /

+0.04 (+0.14%)

10/03/19
Fly Intel: Top five analyst upgrades
10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/03/19 JPMorgan
Dova Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan
09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Upgrade
Fly Intel: Top five analyst upgrades » 10:19
10/03/19
10/03
10:19
10/03/19
10:19
RTN

Merged into RTX

$190.46 /

-0.86 (-0.45%)

, WIT

Wipro

$3.61 /

+0.025 (+0.70%)

, DOVA

Dova Pharmaceuticals

$28.00 /

-0.2 (-0.71%)

, OKTA

Okta

$104.65 /

+1.56 (+1.51%)

, CRWD

Crowdstrike

$57.41 /

+0.76 (+1.34%)

, NEM

Newmont

$38.54 /

+0.68 (+1.80%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Robert Spingarn saying he believes United Technologies' (UTX) aerospace businesses are undervalued and that the market has yet to appropriately discount Raytheon's ~43.1% ownership of the proposed combined entity. 2. Wipro (WIT) upgraded to Neutral from Sell at Goldman Sachs with analyst Sumeet Jain citing valuation. 3. Dova Pharmaceuticals (DOVA) upgraded to Neutral from Underweight at JPMorgan with analyst Joel Fishbein saying the company's "strong" execution continues to drive "impressive growth at scale" as customer deal sizes grow amid larger initial deployments and customers adopting multiple products. 4. Crowdstrike (CRWD) upgraded to Buy from Hold at SunTrust with analyst Joel Fishbein saying the company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption." 5. Newmont Goldcorp (NEM) upgraded to Buy from Hold at Deutsche Bank with analyst Chris Terry saying shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RTN Merged into RTX
$190.46 /

-0.86 (-0.45%)

10/03/19 Credit Suisse
Credit Suisse upgrades Raytheon ahead of merger, boosts target to $230
10/03/19 Credit Suisse
Raytheon upgraded to Outperform from Neutral at Credit Suisse
10/01/19 BofA
Top 10 US Ideas for Q4 at BofA/Merrill
09/17/19 Bernstein
United Technologies price target raised to $154 from $143 at Bernstein
WIT Wipro
$3.61 /

+0.025 (+0.70%)

10/03/19 Goldman Sachs
Wipro upgraded to Neutral from Sell at Goldman Sachs
04/18/19 Nomura Instinet
Wipro downgraded to Reduce from Neutral at Nomura Instinet
04/16/19 Macquarie
Wipro downgraded to Neutral from Outperform at Macquarie
02/26/19 Credit Suisse
Wipro downgraded to Underperform from Neutral at Credit Suisse
DOVA Dova Pharmaceuticals
$28.00 /

-0.2 (-0.71%)

10/03/19 Ladenburg
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/03/19 JPMorgan
Dova Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan
09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
OKTA Okta
$104.65 /

+1.56 (+1.51%)

10/02/19 SunTrust
SunTrust upgrades Okta to Buy on expectations of 30%-plus sales growth
10/02/19 SunTrust
Okta upgraded to Buy from Hold at SunTrust
08/29/19 DA Davidson
Okta price target raised to $131 from $114 at DA Davidson
08/29/19 JPMorgan
Okta price target raised to $168 from $127 at JPMorgan
CRWD Crowdstrike
$57.41 /

+0.76 (+1.34%)

10/02/19 SunTrust
SunTrust upgrades 'category-defining' Crowdstrike to Buy from Hold
10/02/19 SunTrust
Crowdstrike upgraded to Buy from Hold at SunTrust
09/25/19 Baird
Crowdstrike initiated with a Neutral at Baird
09/06/19 Macquarie
Crowdstrike price target raised to $105 from $100 at Macquarie
NEM Newmont
$38.54 /

+0.68 (+1.80%)

10/03/19 Deutsche Bank
Deutsche Bank upgrades Newmont Goldcorp to Buy after underperformance
10/03/19 Deutsche Bank
Newmont Goldcorp upgraded to Buy from Hold at Deutsche Bank
09/12/19 Macquarie
Newmont Goldcorp initiated with a Neutral at Macquarie
09/11/19 BMO Capital
Newmont Goldcorp upgraded to Outperform from Market Perform at BMO Capital
Downgrade
Dova Pharmaceuticals downgraded to Neutral from Buy at Ladenburg » 06:48
10/03/19
10/03
06:48
10/03/19
06:48
DOVA

Dova Pharmaceuticals

$28.20 /

+0.35 (+1.26%)

Ladenburg Thalmann…

Ladenburg Thalmann analyst Matthew Kaplan downgraded Dova Pharmaceuticals to Neutral from Buy and lowered his price target for the shares to $29 from $32. The analyst cites the terms of Dova's agreement to be acquired by Swedish Orphan Biovitrum AB for the downgrade.

ShowHide Related Items >><<
DOVA Dova Pharmaceuticals
$28.20 /

+0.35 (+1.26%)

10/03/19 JPMorgan
Dova Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan
09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
08/29/19
Fly Intel: Top five analyst initiations
Upgrade
Dova Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan » 04:47
10/03/19
10/03
04:47
10/03/19
04:47
DOVA

Dova Pharmaceuticals

$28.20 /

+0.35 (+1.26%)

JPMorgan analyst Anupam…

JPMorgan analyst Anupam Rama upgraded Dova Pharmaceuticals to Neutral from Underweight and raised his price target for the shares to $28 from $16 after the company reached an agreement to acquired by Swedish Orphan Biovitrum.

ShowHide Related Items >><<
DOVA Dova Pharmaceuticals
$28.20 /

+0.35 (+1.26%)

09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
08/29/19
Fly Intel: Top five analyst initiations
08/29/19
Oppenheimer bullish on Dova Pharmaceuticals, initiates with an Outperform
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:43
09/30/19
09/30
16:43
09/30/19
16:43
AAPL

Apple

$224.01 /

+5.1 (+2.33%)

, BA

Boeing

$380.41 /

-2.52 (-0.66%)

, DOVA

Dova Pharmaceuticals

$27.97 /

+7.83 (+38.88%)

, CLNY

Colony Capital

$6.02 /

+0.12 (+2.03%)

, AMZN

Amazon.com

$1,735.91 /

+9.63 (+0.56%)

, JE

Just Energy

$2.37 /

+0.155 (+7.00%)

, THO

Thor Industries

$56.65 /

+7.675 (+15.67%)

, GTHX

G1 Therapeutics

$22.81 /

-11.12 (-32.77%)

, IMMU

Immunomedics

$13.27 /

-1.06 (-7.40%)

Stocks regained some of…

Open Full Text

ShowHide Related Items >><<
AAPL Apple
$224.01 /

+5.1 (+2.33%)

09/30/19 Susquehanna
China macro improves as tech independence accelerates, says Susquehanna
09/30/19 JPMorgan
Apple price target raised to $265 from $243 at JPMorgan
09/27/19 JPMorgan
JPMorgan reiterates Overweight on Netflix with stock down 12% in seven days
09/26/19 UBS
Apple iPhone launch 'appears strong' in U.S., says UBS
BA Boeing
$380.41 /

-2.52 (-0.66%)

09/27/19 Buckingham
Boeing may rise to $425-$450 when investors gain MAX visibility, says Buckingham
09/24/19 Barclays
Barclays sees aerospace aftermarket stocks continuing to outperform in 2020
09/12/19 Morgan Stanley
Boeing CEO update at Laguna conference 'encouraging,' says Morgan Stanley
09/12/19
Embraer upgraded to Buy from Neutral at UBS
DOVA Dova Pharmaceuticals
$27.97 /

+7.83 (+38.88%)

09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
08/29/19
Fly Intel: Top five analyst initiations
08/29/19
Oppenheimer bullish on Dova Pharmaceuticals, initiates with an Outperform
CLNY Colony Capital
$6.02 /

+0.12 (+2.03%)

07/05/19 B. Riley FBR
Northstar Realty Europe sale positive for Colony Capital, says B. Riley FBR
10/05/18
Colony Industrial acquires nine industrial properties in Atlanta
AMZN Amazon.com
$1,735.91 /

+9.63 (+0.56%)

09/30/19 BofA
BofA/Merrill downgrades Ooma to Underperform, sees re-acceleration as unlikely
09/30/19 Jefferies
Jefferies incrementally positive on Trade Desk, Snap after Ad Week
09/26/19 Piper Sandler
Piper believes Amazon Sidewalk is based on Semtech's LoRa
09/25/19 Craig-Hallum
Amazon earbuds a catalyst for Knowles, says Craig-Hallum
JE Just Energy
$2.37 /

+0.155 (+7.00%)

09/30/19 Canaccord
Just Energy activist position viewed positively, says Canaccord
08/22/19 CIBC
Just Energy upgraded to Neutral from Underperformer at CIBC
08/16/19 CIBC
Just Energy downgraded to Underperformer from Neutral at CIBC
05/21/19
Fly Intel: Top five analyst upgrades
THO Thor Industries
$56.65 /

+7.675 (+15.67%)

09/09/19 CL King
Thor Industries downgraded to Neutral from Buy at CL King
09/04/19 BofA
BofA lowers price targets on RV names Camping World, Patrick, Thor
08/08/19 Wellington Shields
Thor Industries downgraded to Hold from Buy at Wellington Shields
06/17/19 Citi
Citi lowers price targets for Thor Industries, United Natural Foods
GTHX G1 Therapeutics
$22.81 /

-11.12 (-32.77%)

08/08/19 JPMorgan
G1 Therapeutics upgraded to Overweight from Neutral at JPMorgan
06/18/19 H.C. Wainwright
G1 Therapeutics trial results 'important,' says H.C. Wainwright
02/07/19 B. Riley FBR
B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target
02/07/19 B. Riley FBR
G1 Therapeutics initiated with a Buy at B. Riley FBR
IMMU Immunomedics
$13.27 /

-1.06 (-7.40%)

09/29/19 Piper Sandler
Piper Jaffray says some may be disappointed by Immunomedics TROPHY response rate
09/10/19 Jefferies
Immunomedics competitor shows 'impressive' efficacy, AEs cause concern, says Jefferies
09/10/19 Piper Sandler
Safety signals arise for potential Immunomedics competitor, says Piper Jaffray
08/20/19
Fly Intel: Top five analyst initiations
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:23
09/30/19
09/30
12:23
09/30/19
12:23
AAPL

Apple

$223.49 /

+4.58 (+2.09%)

, BA

Boeing

$379.25 /

-3.68 (-0.96%)

, DOVA

Dova Pharmaceuticals

$27.96 /

+7.815 (+38.80%)

, SGEN

Seattle Genetics

$85.07 /

+9.06 (+11.92%)

, THO

Thor Industries

$59.40 /

+10.425 (+21.29%)

, GTHX

G1 Therapeutics

$24.99 /

-8.945 (-26.36%)

, IMMU

Immunomedics

$12.38 /

-1.95 (-13.61%)

Stocks have been modestly…

Open Full Text

ShowHide Related Items >><<
AAPL Apple
$223.49 /

+4.58 (+2.09%)

09/30/19 Susquehanna
China macro improves as tech independence accelerates, says Susquehanna
09/30/19 JPMorgan
Apple price target raised to $265 from $243 at JPMorgan
09/27/19 JPMorgan
JPMorgan reiterates Overweight on Netflix with stock down 12% in seven days
09/26/19 UBS
Apple iPhone launch 'appears strong' in U.S., says UBS
BA Boeing
$379.25 /

-3.68 (-0.96%)

09/27/19 Buckingham
Boeing may rise to $425-$450 when investors gain MAX visibility, says Buckingham
09/24/19 Barclays
Barclays sees aerospace aftermarket stocks continuing to outperform in 2020
09/12/19 Morgan Stanley
Boeing CEO update at Laguna conference 'encouraging,' says Morgan Stanley
09/12/19
Embraer upgraded to Buy from Neutral at UBS
DOVA Dova Pharmaceuticals
$27.96 /

+7.815 (+38.80%)

09/30/19 H.C. Wainwright
Dova Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
08/29/19
Fly Intel: Top five analyst initiations
08/29/19
Oppenheimer bullish on Dova Pharmaceuticals, initiates with an Outperform
SGEN Seattle Genetics
$85.07 /

+9.06 (+11.92%)

09/30/19 Stifel
Seattle Genetics' EV-103 data 'stole the spotlight' at ESMO, says Stifel
09/29/19 Piper Sandler
Seattle Genetics price target raised to $95 from $75 at Piper Jaffray
09/29/19 Piper Sandler
Piper Jaffray says some may be disappointed by Immunomedics TROPHY response rate
09/27/19
Fly Intel: Top five analyst upgrades
THO Thor Industries
$59.40 /

+10.425 (+21.29%)

09/09/19 CL King
Thor Industries downgraded to Neutral from Buy at CL King
09/04/19 BofA
BofA lowers price targets on RV names Camping World, Patrick, Thor
08/08/19 Wellington Shields
Thor Industries downgraded to Hold from Buy at Wellington Shields
06/17/19 Citi
Citi lowers price targets for Thor Industries, United Natural Foods
GTHX G1 Therapeutics
$24.99 /

-8.945 (-26.36%)

08/08/19 JPMorgan
G1 Therapeutics upgraded to Overweight from Neutral at JPMorgan
06/18/19 H.C. Wainwright
G1 Therapeutics trial results 'important,' says H.C. Wainwright
02/07/19 B. Riley FBR
B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target
02/07/19 B. Riley FBR
G1 Therapeutics initiated with a Buy at B. Riley FBR
IMMU Immunomedics
$12.38 /

-1.95 (-13.61%)

09/10/19 Jefferies
Immunomedics competitor shows 'impressive' efficacy, AEs cause concern, says Jefferies
09/10/19 Piper Sandler
Safety signals arise for potential Immunomedics competitor, says Piper Jaffray
08/20/19
Fly Intel: Top five analyst initiations

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.